Treatment of hepatitis C in HCV mono-infected and in HIV-HCV coinfected patients: an open-labelled comparison study

Treatment of hepatitis C in HCV mono-infected and in HIV-HCV coinfected patients: an open-labelled comparison study

Bibliographic Details
Main Author:	N Troilliet
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2010-06-01
Series:	Swiss Medical Weekly
Subjects:	Hepatitis C HIV Peginterferon Ribavirin Treatment
Online Access:	https://www.smw.ch/index.php/smw/article/view/1133

Similar Items

Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study
by: D Genné, et al.
Published: (2010-07-01)

Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
by: Young Kul Jung, et al.
Published: (2013-03-01)

Evaluation of Dual Therapy in Real Life Setting in Treatment-Naïve Turkish Patients with HCV Infection: A Multicenter, Retrospective Study
by: Yunus Gürbüz, et al.
Published: (2016-02-01)

Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea
by: Suh Yoon Yang, et al.
Published: (2015-06-01)

The effectiveness of retreatment with peginterferon alfa and ribavirin in patients with chronic viral hepatitis C genotype 2 and 3: a prospective cohort study in Brazil
by: Artico Simara, et al.
Published: (2012-12-01)

HBsAg loss with HBsAg/anti-HBs seroconversion and non-detectable HCV-RNA in a patient with chronic HBV e-minus/HCV hepatitis treated with two cycles of antiviral therapy
by: Antonio Salvio, et al.
Published: (2012-01-01)

Hepatitis C virus infection in patients with hemophilia in Korea: Is antiviral therapy effective and safe?
by: Woo Sun Rou, et al.
Published: (2015-06-01)

The Combination Therapy with Peg-interferon Alfa and Ribavirin for Chronic Hepatitis C in Korea as an Initial Treatment
by: Dong Hyun Park, et al.
Published: (2012-12-01)

Barriers to treatment of hepatitis C in HIV/HCV coinfected adults in Brazil
by: Maria Cássia Mendes-Corrêa, et al.

Treatment of HCV infection in patients with cirrhosis
by: Angelo Alves de Mattos, et al.
Published: (2010-01-01)

Peginterferon alfa-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in retreatment of chronic hepatitis C patients, nonresponders and relapsers to previous conventional interferon plus ribavirin therapy
by: E. Parise, et al.

Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C
by: Seok Hoo Jeong, et al.
Published: (2012-12-01)

Influence of some methylated hepatocarcinogenesis-related genes on the response to antiviral therapy and development of fibrosis in chronic hepatitis C patients
by: Waleed Seif Eldin Mohamed Mostafa, et al.
Published: (2020-01-01)

Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation
by: D Hartwell, et al.
Published: (2011-04-01)

Mycobacterium abscessus pulmonary infection during hepatitis C treatment with telaprevir, peginterferon and ribavirin
by: Alejandro Soza, M.D., et al.
Published: (2015-01-01)

Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin
by: Toyoda Hidenori, et al.
Published: (2012-11-01)

Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavirin in chronic hepatitis C genotype 4
by: Juan José Urquijo, et al.
Published: (2013-01-01)

Pegylated interferon, ribavirin, and frequent supportive therapy with growth factors. Which pathogenesis for a severe psoriasis complicating the treatment of chronic HCV hepatitis?
by: Roberto Manfredi
Published: (2009-12-01)

Hepatic fibrosis in patients with chronic hepatitis C assessed by transient elastography: implications for determining the efficacy of antiviral therapy Evaluación de la fibrosis hepática en pacientes con hepatopatía crónica C mediante elastografía transitoria: implicaciones para determinar la eficacia del tratamiento antiviral
by: J. Mendoza, et al.
Published: (2010-07-01)

A Practical Approach to Managing Patients with HCV Infection
Published: (2006-04-01)

Experimental models for hepatitis C virus (HCV): New opportunities for combating hepatitis C
by: Karina del Carmen Trujillo-Murillo, Ph.D., et al.
Published: (2004-04-01)

Immunological aspects of HCV/HIV coinfection
by: Nikolay Dmitrievich Yushchuk, et al.
Published: (2011-11-01)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
by: Janine Hartl, et al.
Published: (2012-07-01)

Interferon-based Simeprevir Therapy for Pediatric Patients with Chronic Hepatitis C Viral Infection
by: Mitsuyoshi Suzuki, et al.
Published: (2018-09-01)

Efficacy and safety of peginterferon alfa-2a and ribavirin treatment of chronic hepatitis C in the Republic of Serbia
by: Božić Milena, et al.
Published: (2012-01-01)

Cryoglobulinemic glomerulonephritis: an extrahepatic manifestation of hepatitis C virus (HCV) infection
by: Giovanni Garini, et al.
Published: (2007-12-01)

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals
by: Silvia Molina-Carrión, et al.
Published: (2020-07-01)

HCV-HIV Chronic Coinfection Prevalence in Amazon Region
by: Marcio Nahum Lobo, et al.
Published: (2022-12-01)

Hepatitis B virus surface antigen seroconversion in HIV-infected individual after pegylated interferon-alpha treatment: a case report
by: Adriane Maira Delicio, et al.
Published: (2013-12-01)

No gender differences in the 24-month course of non-invasive liver fibrosis markers after DAA therapy in HCV-mono and HCV/HIV-coinfected patients
by: Julio Collazos, et al.
Published: (2024-03-01)

Epidemiology of HIV/HCV coinfection in patients cared for at the Tropical Medicine Foundation of Amazonas
by: Marilú Barbieri Victoria, et al.

Current concepts in the management and treatment of hepatitis C in HIV-infected patients
by: Marina Núñez, et al.
Published: (2005-07-01)

Depression in Individuals Coinfected with HIV and HCV Is Associated with Systematic Differences in the Gut Microbiome and Metabolome
by: Bryn C. Taylor, et al.
Published: (2020-10-01)

Treatment with pegylated interferon alpha 2b and ribavirin in patients unresponsive to previous treatments with standard interferon as monotherapy or combined with ribavirin Tratamiento con PEG interferón alfa 2b y ribavirina en enfermos previamente tratados con interferón estándar en monoterapia o combinado con ribavirina
by: F. Carnicer, et al.
Published: (2005-05-01)

Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin
by: Tatsuo Kanda, et al.
Published: (2017-05-01)

HCV treatment in children and young adults with HIV/HCV co-infection in Europe
by: Anna Turkova, et al.
Published: (2015-07-01)

The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis
by: Liu Jun-Ying, et al.
Published: (2012-09-01)

Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH)
by: Saskia Antwerpes, et al.
Published: (2020-08-01)

Survival analysis over a 20-year period of a Brazilian cohort of blood donors coinfected HIV-HCV
by: Hélio Ranes de Menezes Filho, et al.
Published: (2023-09-01)

Profile of HIV subtypes in HIV/HBV- and HIV/HCV-coinfected patients in Southern Brazil
by: Valéria Miranda Avanzi, et al.